|
| 37225491 | Serum Zinc-α2-glycoprotein Levels Are Associated with the Hepatorenal Function and Predict the Survival in Cases of Chronic Liver Disease. | Intern Med | 2024 |
| 36824614 | Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients. | Front Med (Lausanne) | 2023 |
| 37893181 | Extracellular Vesicles as Therapeutic and Diagnostic Tools for Chronic Liver Diseases. | Biomedicines | 2023 |
| 35732454 | Hepatocellular Carcinoma Pseudoprogression Involving the Main Portal Vein, Right Ventricular Invasion, and Exacerbation of Lung Metastases in a Patient on Atezolizumab Plus Bevacizumab. | Intern Med | 2023 |
| 36462157 | Extracellular vesicles in fatty liver disease and steatohepatitis: Role as biomarkers and therapeutic targets. | Liver Int | 2023 |
| 34555251 | Extracellular vesicles from pancreatic ductal adenocarcinoma endoscopic ultrasound-fine needle aspiration samples contain a protein barcode. | J Hepatobiliary Pancreat Sci | 2022 |
| 35380992 | Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis. | J Clin Invest | 2022 |
| 35485207 | A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis. | Hepatol Commun | 2022 |
| 36206032 | Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans. | Elife | 2022 |
| 36035413 | Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease. | Front Med (Lausanne) | 2022 |
| 36199236 | Complement complex 1 subunit q-mediated hepatic stellate cell activation with connective tissue growth factor elevation is a prognostic factor for survival in rat and human chronic liver diseases. | Hepatol Commun | 2022 |
| 35885492 | Development of a New Index to Distinguish Hepatic Encephalopathy through Automated Quantification of Globus Pallidal Signal Intensity Using MRI. | Diagnostics (Basel) | 2022 |
| 36317773 | The prognostic role of controlling nutritional status and skeletal muscle mass in patients with hepatocellular carcinoma after curative treatment. | Eur J Gastroenterol Hepatol | 2022 |
| 36081568 | The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage. | Front Oncol | 2022 |
| 33797850 | Accuracy of carbohydrate-deficient transferrin as a biomarker of chronic alcohol abuse during treatment for alcoholism. | Hepatol Res | 2022 |
| 35264978 | Cell-to-Cell Communications in Alcohol-Associated Liver Disease. | Front Physiol | 2022 |
| 35194091 | Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis. | Sci Rep | 2022 |
| 32954793 | The TAT Protein Transduction Domain as an Intra-Articular Drug Delivery Technology. | Cartilage | 2021 |
| 33743328 | Branched-chain amino acids protect the liver from cirrhotic injury via suppression of activation of lipopolysaccharide-binding protein, toll-like receptor 4, and signal transducer and activator of transcription 3, as well as Enterococcus faecalis translocation. | Nutrition | 2021 |
| 33534129 | The Role of Elevated Liver-Type Fatty Acid-Binding Proteins in Liver Diseases. | Pharm Res | 2021 |
| 34521905 | Development of a highly sensitive chemiluminescent enzyme immunoassay for fragmented cytokeratin 18 using new antibodies. | Sci Rep | 2021 |
| 34816010 | Update on blood-based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience. | JGH Open | 2021 |
| 34719623 | Serum Copeptin and Zinc-α2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites. | Intern Med | 2021 |
| 34276412 | Protein Composition of Circulating Extracellular Vesicles Immediately Changed by Particular Short Time of High-Intensity Interval Training Exercise. | Front Physiol | 2021 |
| 34263080 | Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy. | JGH Open | 2021 |
| 34146255 | Plexin domain containing protein 2 is more expressed within the invasive area of human colorectal cancer tissues. | Hum Cell | 2021 |
| 33395607 | Branched-chain amino acids and l-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liver. | Biomed Pharmacother | 2021 |
| 32763266 | Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis. | J Hepatol | 2021 |
| 32790956 | Serum copeptin level is a biomarker associated with ascites retention and the formation of a portosystemic shunt in chronic liver disease. | J Gastroenterol Hepatol | 2021 |
| 32556367 | Comprehensive characterization of hepatocyte-derived extracellular vesicles identifies direct miRNA-based regulation of hepatic stellate cells and DAMP-based hepatic macrophage IL-1β and IL-17 upregulation in alcoholic hepatitis mice. | J Mol Med (Berl) | 2020 |
| 31759091 | Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome. | Brain Behav Immun | 2020 |
| 32857769 | Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma. | PLoS One | 2020 |
| 32923831 | Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH. | Hepatol Commun | 2020 |
| 32202949 | Expression Pattern of Plexin Domain Containing 2 in Human Hepatocellular Carcinoma. | Monoclon Antib Immunodiagn Immunother | 2020 |
| 31168516 | Serum Liver-Type Fatty Acid-Binding Protein Is a Possible Prognostic Factor in Human Chronic Liver Diseases From Chronic Hepatitis to Liver Cirrhosis and Hepatocellular Carcinoma. | Hepatol Commun | 2019 |
| 30036273 | Integrin and PD-1 Ligand Expression on Circulating Extracellular Vesicles in Systemic Inflammatory Response Syndrome and Sepsis. | Shock | 2019 |
| 30005446 | Ratio between estimated glomerular filtration rates of creatinine and cystatin C predicts overall survival in patients with hepatocellular carcinoma. | Hepatol Res | 2019 |
| 31184999 | Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis. | JCI Insight | 2019 |
| 31240767 | Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus-related liver cirrhosis. | Hepatol Res | 2019 |
| 30982591 | Extracellular vesicles, the liquid biopsy of the future. | J Hepatol | 2019 |
| 30859103 | Circulating Extracellular Vesicles and Their miR "Barcode" Differentiate Alcohol Drinkers With Liver Injury and Those Without Liver Injury in Severe Trauma Patients. | Front Med (Lausanne) | 2019 |
| 28902427 | NLRP3 inflammasome driven liver injury and fibrosis: Roles of IL-17 and TNF in mice. | Hepatology | 2018 |
| 29944389 | Circulating extracellular vesicles are associated with lipid and insulin metabolism. | Am J Physiol Endocrinol Metab | 2018 |
| 30084831 | Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice. | J Lipid Res | 2018 |
| 30322964 | Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis. | J Immunol | 2018 |
| 30345152 | Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases. | Liver Res | 2018 |
| 29728708 | Emricasan, a pan-caspase inhibitor, improves survival and portal hypertension in a murine model of common bile-duct ligation. | J Mol Med (Berl) | 2018 |
| 29115717 | Changes in liver function and body composition by direct-acting antiviral therapy for hepatitis C virus infection. | Hepatol Res | 2018 |
| 27639178 | Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood. | Hepatology | 2017 |
| 28381740 | The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD). | Intern Med | 2017 |